CLINICAL_TRIALS
research
· 2026-04-09
Clinical Trial Update: A Phase I Clinical Study to Evaluate the PK, PD, Efficacy, and Safety of GB18 Injection in Patients With Tumor Cachexia [Phase 1]
Summary
Phase I clinical study to evaluate pharmacokinetics, pharmacodynamics, efficacy, and safety of GB18 Injection in patients with tumor cachexia; status listed as …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Kexing Biopharm Co., Ltd. | Conditions: Cachexia; Cancer | Phase 1 | Status: NOT_YET_RECRUITING